Nuwellis, Inc. (NUWE) stock
NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/3082% below fair value
$5.03−0.50 (-9.04%)
Close on Nov 12, 2026Market cap $2.72MP/E –Yield –
Nuwellis ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Nuwellis's ebitda for the twelve months ending Sep 30, 2026 was -$12.09M. For fiscal 2025 it was -$10.91M. The highest annual figure on record is -$10.68M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.91M | – |
| FY2024 | Dec 31, 2024 | -$10.68M | – |
| FY2023 | Dec 31, 2023 | -$17.27M | – |
| FY2022 | Dec 31, 2022 | -$16.80M | – |
| FY2021 | Dec 31, 2021 | -$19.04M | – |
| FY2020 | Dec 31, 2020 | -$16.65M | – |
| FY2019 | Dec 31, 2019 | -$17.87M | – |
| FY2018 | Dec 31, 2018 | -$16.80M | – |
| FY2017 | Dec 31, 2017 | -$14.04M | – |
| FY2016 | Dec 31, 2016 | -$14.97M | – |
| FY2015 | Dec 31, 2015 | -$25.63M | – |
| FY2014 | Dec 31, 2014 | -$25.51M | – |
| FY2013 | Dec 31, 2013 | -$22.69M | – |
| FY2012 | Dec 31, 2012 | -$14.73M | – |
| FY2011 | Dec 31, 2011 | -$16.51M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.02M | – |
| Q2 FY2026 | Jun 30, 2026 | -$3.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.53M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.41M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.65M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.86M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.99M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.30M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.25M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.67M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.48M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.94M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.77M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.46M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.83M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.20M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.31M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.23M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.12M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.60M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.09M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.16M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.16M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.83M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.50M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.39M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.45M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.37M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.67M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.20M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.19M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.12M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.30M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.03M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.64M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.28M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.09M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.82M | – |
See a number that looks wrong?